Neuronetics Q2 Earnings Call Highlights

Source: MarketBeat· MarketBeat· August 11, 2026
Neuronetics Q2 Earnings Call Highlights
SynaBot summary

Neuronetics reported strong Q2 2026 financial performance, with revenue climbing 9.1% to $41.6 million. The company also achieved a significantly reduced net loss and positive adjusted EBITDA, driven by its Greenbrook clinic operations.

Key takeaways

  • Revenue increased 9.1% to $41.6 million in Q2 2026.
  • Net loss narrowed considerably compared to the previous year.
  • Positive adjusted EBITDA achieved, signaling operational profitability.
  • Growth driven by Greenbrook clinic business segment.

Why it matters

This financial improvement for Neuronetics, a company focused on neurostimulation, indicates growing market adoption and operational efficiency. For AI users, it suggests potential for increased investment and development in AI-driven healthcare solutions, impacting future tool availability and capabilities.

This story was reported by MarketBeat. Read the full original article:
Read on MarketBeat

Try this on SynaBot

Related AI assistants, prompts, and tools from the SynaBot catalog.

More in Business & Funding

View all